Media briefing on COVID-19 - 03/05/2021
Date:
03/05/2021
Good morning, good afternoon and good evening.
Earlier today, the government of the Democratic Republic of the Congo announced the end of the most recent Ebola outbreak, three months after the first case was reported in North Kivu.
I congratulate the government, health workers, communities and all WHO staff who were involved in the response.
This has only been possible thanks to a concerted, compr...
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Viral Vaccines/supply & distribution, Pandemics/prevention & control, Health Consortia, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Health Equity/economics, Healthcare Financing, Immunization Programs/organization & administration, Hemorrhagic Fever, Ebola/prevention & control, Access to Essential Medicines and Health Technologies, Hospital Bed Capacity, Home Nursing/organization & administration, Dexamethasone/therapeutic use, Dissolved Oxygen, Social Isolation, Quarantine/organization & administration, India/epidemiology, Brazil/epidemiology, COVID-19, Covax, Ghebreyesus, Tedros Adhanom, AstraZeneca, Moderna
Acompanhe ao vivo nossa sessão virtual de perguntas e respostas sobre COVID-19. Tire suas dúvidas!
Date:
30/03/2021
Acompanhe ao vivo nossa sessão virtual de perguntas e respostas sobre COVID-19. Tire suas dúvidas!
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Viral Vaccines/immunology, Immunization Programs/organization & administration, Social Isolation, Quarantine, Masks, Brazil/epidemiology, Risk Groups, Epidemiological Monitoring, Betacoronavirus/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, DNA, Viral/genetics, Mutation/genetics, COVID-19
Coletiva de imprensa: anúncio dos avanços nas pesquisas contra o Coronavírus
Date:
26/03/2021
O Governador João Doria anunciou nesta sexta-feira (26) que o Instituto Butantan, ligado ao Governo do Estado de São Paulo, iniciou o desenvolvimento e a produção-piloto da primeira vacina brasileira contra o novo coronavírus. A expectativa é que os ensaios clínicos de fases 1 e 2 em humanos com o novo imunizante comecem já em abril, após autorização da Anvisa (Agência Nacional de Vigi...
See more details
Betacoronavirus/immunology, Pneumonia, Viral/immunology, Coronavirus Infections/immunology, Viral Vaccines/supply & distribution, Pandemics/prevention & control, Immunization Programs/organization & administration, Brazil, Brazilian Health Surveillance Agency, Governmental Research Institutes, Investments/economics, COVID-19, Instituto Butantan, ButanVac, Plano São Paulo, Doria, João, Sinovac Biotech, Insumo Farmacêutico Ativo
Coletiva do lançamento do Plano Nacional de operacionalização da vacina contra a COVID-19
Date:
16/12/2020
Durante o lançamento do Plano Nacional de Operacionalização da Vacina contra a Covid-19, na manhã desta quarta-feira (16/12), o ministro da Saúde, Eduardo Pazuello, reforçou o compromisso do Governo Federal em incorporar todas as vacinas contra o coronavírus que obtiverem o aval da Agência Nacional de Vigilância Sanitária (Anvisa). “Todas as vacinas produzidas no Brasil, ou pelo Butant...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Brazil/epidemiology, Risk Groups, Brazilian Health Surveillance Agency, Social Isolation, Masks, Clinical Trial, Phase III, Mobile Applications, Health Promotion, Local Health Systems/organization & administration, COVID-19, Pazuello, Eduardo, Astrazeneca, Vacina de Oxford, Fiocruz, Instituto Butantan, Sinovac Biotech, Coronavac
Com o Brasil unido contra COVID-19!
Date:
10/12/2020
O Ministério da Saúde trabalha para garantir a vacinação de todos os brasileiros. O secretário-executivo, Elcio Franco, garantiu que a união de estados, municípios, Governo Federal e população fortalece o Brasil no combate à Covid-19. Assista aos trechos da coletiva!
See more details
Pandemics/prevention & control, Viral Vaccines/supply & distribution, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Betacoronavirus/immunology, Brazil, Immunization Programs/organization & administration, COVID-19
Ministério da Saúde atualiza informações sobre o combate à COVID-19
Date:
10/12/2020
Siga o Ministério da Saúde
http://www.twitter.com/minsaude
http://www.facebook.com/minsaude
http://www.instagram.com/minsaude
https://www.linkedin.com/company/mini...
See more details
Betacoronavirus/immunology, Pandemics/statistics & numerical data, Viral Vaccines/supply & distribution, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Brazil/epidemiology, Local Health Systems/economics, Healthcare Financing, Intensive Care Units/statistics & numerical data, Ventilators, Mechanical/supply & distribution, Hospital Bed Capacity/statistics & numerical data, Health Centers, Primary Health Care/organization & administration, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Intubation, Hypnotics and Sedatives/supply & distribution, Epidemiological Monitoring, Health of Indigenous Peoples, Health Information Management, Unified Health System/organization & administration, Strategic Stockpile/statistics & numerical data, Brazilian Health Surveillance Agency, Mass Vaccination/organization & administration, COVID-19, Astrazeneca
Azul se compromete a transportar, de graça, vacinas contra a COVID-19
Date:
09/12/2020
Vacina contra COVID-19 será distribuída pela Azul Linhas Aéreas, gratuitamente, nos quatro cantos do Brasil, em parceria com o governo federal. O acordo vai garantir mais agilidade e segurança ao processo de transporte da vacina para população brasileira. Saiba mais em gov.br/saude
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Betacoronavirus/immunology, Viral Vaccines/supply & distribution, Brazil, Brazilian Health Surveillance Agency, COVID-19, Pfizer, Instituto Butantan, Azul Linhas Aérea
Governo assegura 300 milhões de doses de vacinas contra a COVID-19 para 2021
Date:
08/12/2020
O Governo Federal já garantiu 300 milhões de doses de vacinas contra a Covid-19 para 2021. Os números referem-se aos acordos com a AstraZeneca e Covax Facility; o ministro Eduardo Pazuello também reafirmou que vacina será acessível a todos os brasileiros. Saiba mais em gov.br/saude
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Brazil/epidemiology, COVID-19, AstraZeneca, Covax Facility, Pazuello, Eduardo
I Seminário Nacional do Conass e Conasems - 09/12/2020
Date:
09/12/2020
As inscrições para o I Seminário Conass e Conasems encerram amanhã (terça-feira, 08), às 18h.
O impacto da pandemia de Covid-19 nos serviços de saúde e a resposta do SUS serão os principais temas abordados no I Seminário Nacional do Conass e Conasems. O evento, que será realizado de forma virtual, ocorrerá entre os dias 9 e 11 de dezembro, sempre entre 14h30 e 18h.
As experiências be...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Chronic Disease/prevention & control, Betacoronavirus/immunology, Pneumonia, Viral/prevention & control, Coronavirus Infections/prevention & control, Viral Vaccines/supply & distribution, Health Councils/organization & administration, Unified Health System/organization & administration, Congress, Brazil/epidemiology, Public Health Systems, Elective Surgical Procedures, Social Isolation, Masks, Financial Resources in Health/economics, Primary Health Care/organization & administration, Personal Protective Equipment/supply & distribution, Noncommunicable Diseases/prevention & control, Health Personnel/organization & administration, Hospital Administration, Equity in Access to Health Services, Telemedicine, Health Management, Pandemics/statistics & numerical data, Polymerase Chain Reaction/statistics & numerical data, Coronavirus Infections/diagnosis, Pneumonia, Viral/diagnosis, Governmental Research Institutes, Clinical Trial, Phase III, Healthy Volunteers, Brazilian Health Surveillance Agency, Immunization Programs/organization & administration, Vaccine Potency, COVID-19, Pazuello, Eduardo , Coronavac, Instituto Butantan, Sinovac Biotech, Pfizer, Astrazeneca, Fiocruz, Vacina de Oxford
Ministério da Saúde apresenta balanço de ações contra a COVID-19
Date:
03/11/2020
Siga o Ministério da Saúde
http://www.twitter.com/minsaude
http://www.facebook.com/minsaude
http://www.instagram.com/minsaude
https://www.linkedin.com/company/mini...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/statistics & numerical data, Local Health Systems/organization & administration, Epidemiological Monitoring, Financial Resources in Health/economics, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Ventilators, Mechanical/supply & distribution, Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Personal Protective Equipment/supply & distribution, Primary Health Care/economics, Chloroquine/supply & distribution, Hydroxychloroquine/supply & distribution, Oseltamivir/supply & distribution, Brazil/epidemiology, Health Personnel/organization & administration, Coronavirus Infections/diagnosis, Pneumonia, Viral/diagnosis, Polymerase Chain Reaction/statistics & numerical data, Viral Vaccines/supply & distribution, Clinical Trial, Phase III, Immunization Programs/organization & administration, Risk Groups, COVID-19, Covax, Vacina de Oxford, Coronavac
